SEC Form 4 · accession 0001567619-18-006729
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J. Farrell
Officer — Chief Executive Officer
Period of report
Nov 16, 2018
Accepted (ET)
Nov 20, 2018 · 11:58 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Nov 16, 2018 | A | 13,640 | $0.00 | A | 13,640 | I | Lissette and Michael Farrell Family Trust |
| ResMed Common Stock | Nov 16, 2018 | G | 3,300 | $0.00 | D | 10,340 | I | Lissette and Michael Farrell Family Trust |
| ResMed Common StockF3 | Nov 16, 2018 | G | 3,300 | $0.00 | A | 3,300 | I | Lissette and Michael Farrell Family Foundation |
| ResMed Common Stock | Nov 16, 2018 | S | 3,300 | $104.49 | D | 0 | I | Lissette and Michael Farrell Family Foundation |
| ResMed Common Stock | holding | — | — | — | 240,487 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Acquisition originates from a maturity distribution of the Charitable Income Trust II to beneficiaries.
- F2Represents a gift to the Lisette and Michael Farrell Family Foundation, a 501(c)(3) non-profit corporation.
- F3Mr. and Mrs. Farrell retain dispositive power over foundation holdings.